| Drug Resistance in Cancer: An Overview | 2014/09/05 | English | 1,537 |
| Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects | 2011/03/15 | English | 1,184 |
| Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment | 2014/08/13 | English | 1,037 |
| Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways | 2017/05/17 | English | 973 |
| Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence | 2020/03/20 | English | 752 |
| Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions | 2017/02/18 | English | 638 |
| Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth | 2015/12/11 | English | 519 |
| Assessment of the Evolution of Cancer Treatment Therapies | 2011/08/12 | English | 513 |
| A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer | 2019/10/22 | English | 473 |
| Cell Death Pathways in Photodynamic Therapy of Cancer | 2011/06/03 | English | 458 |
| Cytokines in Cancer Immunotherapy | 2011/10/13 | English | 438 |
| Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review | 2021/08/25 | English | 429 |
| Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors | 2016/02/15 | English | 390 |
| Role of p53 in Cell Death and Human Cancers | 2011/03/03 | English | 387 |
| Flavonoids in Cancer and Apoptosis | 2018/12/28 | English | 384 |
| Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems | 2019/05/08 | English | 372 |
| STAT3 Target Genes Relevant to Human Cancers | 2014/04/16 | English | 344 |
| Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy | 2016/03/15 | English | 341 |
| Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment | 2018/10/11 | English | 326 |
| JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression | 2019/12/12 | English | 322 |
| Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis | 2017/12/16 | English | 317 |
| Gut Microbiota and Cancer: From Pathogenesis to Therapy | 2019/01/03 | English | 308 |
| Exploring the Role of RGD-Recognizing Integrins in Cancer | 2017/09/04 | English | 289 |
| A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis | 2021/04/22 | English | 282 |
| Pancreatic Cancer Chemoresistance to Gemcitabine | 2017/11/16 | English | 279 |
| Reactive Oxygen Species in the Tumor Microenvironment: An Overview | 2019/08/16 | English | 262 |
| Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy | 2020/03/20 | English | 257 |
| Targeting RTK Signaling Pathways in Cancer | 2015/09/03 | English | 248 |
| Exosomes in Cancer Diagnostics | 2017/01/12 | English | 238 |
| Glutathione in Cancer Cell Death | 2011/03/11 | English | 235 |